Table 1. Univariate and multivariate stepwise backwards linear regression analyses.

		Univariate analysis			Multivariate analysis
Peak	Coeff.	95% CI	p-value	Coeff.	95% CI	p-value
P1	0.035	[−0.260–0.329]	0.816	NS	NS	NS
P2–P6	0.024	[0.012–0.035]	0.000	0.016	[0.004–0.029]	0.010
P7–P20	0.038	[−0.015–0.091]	0.160	NS	NS	NS
P21–P26	0.018	[0.005–0.031]	0.007	0.013	[0.0005–0.026]	0.042
P27–P32	0.007	[−0.112–0.126]	0.907	NS	NS	NS
P33–P38	0.023	[0.002–0.044]	0.032	NS	NS	NS
P39–P46	0.021	[−0.043–0.085]	0.519	NS	NS	NS
P47–P49	0.094	[0.023–0.165]	0.010	0.076	[0.009–0.143]	0.028
P50–P58	0.024	[−0.014–0.061]	0.207	NS	NS	NS
P59–P62	0.018	[−0.012–0.047]	0.238	NS	NS	NS

The table shows the association between the ability of DBL4ε anti-sera to inhibit binding of VAR2CSA expressing infected erythrocytes to CSA and the level of antibodies to the individual peptides. Antibody reactivity to groups of DBL4ε peptides according to the reactivity shown in figure 2A. NS: Not Significant.